By Dr. Mercola Immunotherapy drugs are considered the latest and greatest breakthrough in conventional cancer treatment. Chimeric antigen receptor technology (CAR-T) has raised a great deal of hope, and an equal measure of concern. CAR-T involves genetically re-engineering a patient’s immune cells to target tumor-associated antigens, thereby destroying the malignant cells. Alas, while these therapies appear to be quite effective at attacking and destroying malignant cells, they can also take a toll on healthy tissues and organs, leaving many patients struggling for their lives, albeit for an entirely different reason. There’s also another important issue at stake here. CAR-T cell … Continue reading Immunotherapy for Cancer?